Biotech Thinking Comes to Academic Medical Centers

See allHide authors and affiliations

Science  28 Feb 2003:
Vol. 299, Issue 5611, pp. 1303-1305
DOI: 10.1126/science.299.5611.1303

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A novel enterprise at Harvard Medical School called the Laboratory for Drug Discovery in Neurodegeneration could provide a model for how to translate academic research into new drugs that industry is unlikely to pursue. Although its success is tied to developing commercially successful drugs, it is not tied to ever making a profit on those drugs--just enough money to keep the operation running.